probenecid has been researched along with Cancer of Kidney in 2 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roch-Ramel, F | 2 |
| Werner, D | 1 |
| Guisan, B | 2 |
| Diezi, J | 1 |
2 other studies available for probenecid and Cancer of Kidney
| Article | Year |
|---|---|
Urate transport in brush-border membrane of human kidney.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Aged; Biological Transport; Carbon Radioisotopes; Carbonyl Cya | 1994 |
Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles.
Topics: Aged; Benzbromarone; Biological Transport; Biphenyl Compounds; Carbon Radioisotopes; Diuretics; Etha | 1997 |